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IRENE’s mission is to improve the health and well-being of Iowans 
through collaboration in practice-based research on questions 
important to primary care physicians and their patients.  IRENE’s 
purpose is to create and foster a network of research collaboration 
between the academic medical center and primary care physicians 
throughout the state of Iowa with a particular focus on improving 
rural health. 
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INFORMATION ABOUT... 
 
Fecal Immunochemical Test 
 
The fecal immunochemical test (FIT) is a newer kind of test that detects occult blood in the stool. This test reacts to part of 
the human hemoglobin protein, rather than to heme as in guaiac-based testing.    
 
FIT Types 
 Manual liquid-based results which read negative/positive, CLIA-waived  
 (Examples: Quidel QuickVue iFOB) 
 Automated liquid-based results which read Hb ng/ml or negative/positive, not CLIA-waived 
 (Examples: OC-Auto Micro 80)  
 Manual dry-slide results read which negative/positive, CLIA-waived  
 (Examples: Beckman Coulter Hemoccult ICT, Immunostics Heme Screen Specific) 
 
FIT Important Points 
 Highly specific for occult lower gastrointestinal (GI) bleeding, as globin is degraded by upper GI                               
enzymes; thus FIT is not suitable for detecting upper GI bleeding; use guaiac test for that 
 No dietary or medication restrictions for stool collection 
 Automated FIT has shown better performance characteristics than guaiac tests using three stool samples*: 
 Guaiac (Beckman Coulter Hemoccult II) sensitivity and specificity for detecting advanced adenomas (14%/92%), 
cancer (31%/92%), and advanced colorectal neoplasm (17%/93%) 
 FIT (OC-Sensor) sensitivity and specificity for detecting advanced adenomas (34%/91%), cancer (85%/90%), and 
advanced colorectal neoplasm (44%/92%)1 
 Hemoglobin in stool samples stored in liquid-based buffer degrades over time 
 Mailed dry-slide stool samples have better stability of hemoglobin compared with liquid-based tests 
 May not detect a non-bleeding tumor, so multiple stool samples still should be tested; two stool samples are 
recommended 
 Avoid digital rectal exam to obtain stool sample 
 Trauma of exam could cause bleeding 
 Sensitivity for detecting advanced neoplasia in 284 patients was 4.9% for digital rectal exam and 23.9% for            
6-sample guaiac FOBT2 
 A positive FIT indicates a need for complete colonoscopy  
 
1Park D, Seungho R, Kim Y, et al., Comparison of guaiac-based and qualitative immunochemical fecal occult blood testing in a population at average risk undergoing 
colorectal cancer screening. Am J Gastroenterol 2010;105:2017-2025. 
2Collins JF, Lieberman DA, Durbin TE, et al. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: A comparison 
with recommended sampling practice. Ann Intern Med 2005;142:81-85. 
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FUNDING OPPORTUNITIES 
 
NEW GRANT FUNDING SOURCE: PCORI 
 
The Patient-Centered Outcomes Research Institute (PCORI) is an independent 
organization created to help people make informed health care decisions and 
improve health care delivery. 
 
PCORI was created by Congress through the Patient Protection and Affordable Care Act of 2010 as a non-profit, 
nongovernmental organization, governed by a 21-member Board of Governors. PCORI’s purpose, as defined by 
the law, is to help patients, clinicians, purchasers, and policy makers make better-informed health decisions by 
“advancing the quality and relevance of evidence about how to prevent, diagnose, treat, monitor, and manage 
diseases, disorders, and other health conditions.” 
 
The statutory language defining PCORI is broad and authorizes research that will support a strong patient-
centered orientation, inform better choices among alternative treatment and prevention strategies, and direct 
attention to individual and system differences that may influence strategies and outcomes. PCORI was designed 
to produce knowledge through the analysis and synthesis of existing research or the support of new research. 
 
PCORI’s Proposed Research Agenda 
Below is the first version of PCORI’s Research Agenda. PCORI expects to learn and update this over time. 
 Assessment of Prevention, Diagnosis, and Treatment Options. Research should focus on 1) clinical 
options with emphasis on patient preferences and decision-making, 2) biological, clinical, social, 
economic, and geographic factors that may affect patient outcomes. 
 Improving Healthcare Systems. Research should focus on 1) ways to improve access to care, receipt 
of care, coordination of care, self-care, and decision-making, 2) use of non-physician healthcare 
providers, such as nurses and physician assistants, and the impact on patient outcomes, 3) system-
level changes affecting all populations, diseases, and health conditions. 
 Communication and Dissemination. Research should focus on 1) strategies to improve patient and 
clinician knowledge about prevention, diagnosis and treatment options, 2) methods to increase 
patient participation in care and decision-making and the impact on health outcomes, 3) 
communication tools that enhance decision-making and achieve desired outcomes, 4) ways to use 
electronic data (“e-health records”) to support decision-making, 5) best practices for sharing research 
results. 
 Addressing Disparities. Research should focus on 1) ways to reduce disparities in health outcomes, 
2) benefits and risks of healthcare options across populations, 3) strategies to address healthcare 
barriers that can affect patient preferences and outcomes. 
 Accelerating Patient-Centered and Methodological Research. Research should focus on 1) ways to 
improve the quality and usefulness of clinical data in follow-up studies, 2) methods to combine and 
analyze clinical data that follow patients over time, 3) use of registries and clinical data networks to 
support research about patient-centered outcomes, including rare diseases, 4) strategies to train 
researchers and enable patients and caregivers to participate in patient-centered outcomes 
research. 
 
PCORI has released one call for pilot projects to assist in development of research agenda, collection of 
preliminary data to advance the field of patient-centered outcomes research, and identify methodologies that 
can be used to advance patient-centered outcomes research. We will keep you apprised of future PCORI grant 
program announcements. 
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Iowa Primary Care Infrastructure Training (2012) 
Funded by NIH National Cancer Institute Grant 
 
AUG 8, 2012  — HOTEL WINNESHIEK, 104 EAST WATER STREET, DECORAH, IA 
 
Please join the Iowa Community-Based Cancer Prevention Project for a FREE infrastructure building session for all Iowa Family 
Medicine and Iowa Research Network (IRENE) Clinics.  Participants will learn how their clinic may participate in current and future 
research projects.  NURSES,  MEDICAL ASSISTANTS, OTHER OFFICE STAFF, AND HEALTHCARE PROVIDERS ARE 
WELCOME. 
 
 3.25 AMA PRA Category 1 Credits™ awarded to physicians at no charge.  
 Nurses:  Full time attendance will award 7.2 contact hours. 
 Each participating IRENE clinic will receive an E-TABLET or COMPUTER & PRINTER for patient education and 
research in the clinic 
 Travel costs will be reimbursed (mileage, meals and hotel, if needed) 
 Attendees will be trained in Human Subjects Protection ($200/person or up to $400 incentive for each office completing the 
training) 
 Participating clinics will be eligible for travel support for future meetings 
 
Credit 
Physicians 
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing 
Medical Education (ACCME) through the joint sponsorship of the University of Iowa Roy J. and Lucille A. Carver College of Medicine and The Iowa 
Cancer Consortium and the Department of Family Medicine. The UI Carver College of Medicine is accredited by the ACCME to provide continuing 
medical education for physicians. 
 
The University of Iowa Carver College of Medicine designates this live activity for a maximum of 3.25 AMA PRA Category 1 Credits™.  Physicians 
should claim only the credit commensurate with the extent of their participation in the activity. 
 
DISCLOSURE POLICY:  
Everyone in a position to control the content of this educational activity will disclose to the CME provider (University of Iowa Carver College of 
Medicine) and to attendees all relevant financial relationships with any commercial interests. They will also disclose if any pharmaceuticals or medical 
procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). 
 
Nurses 
This program is offered in cooperation with the University of Iowa College of Nursing, an Iowa Board of Nursing approved provider, number 1. Full 
time attendance will award 7.2 contact hours.  Program number 12 221 93 has been assigned for the August 8 session in Decorah. 
8:15 a.m. REGISTRATION & CHECK-IN (Coffee, Juice and light breakfast available) 
8:45  WELCOME/INTRODUCTIONS 
 
OVERVIEW: BUILDING INFRASTRUCTURE FOR CANCER CONTROL IN IOWA AND THE IOWA RESEARCH NETWORK (IRENE) 
Barcey Levy, PhD, MD, Professor, University of Iowa Department of Family Medicine  
9:30  HUMAN SUBJECTS PROTECTIONS CERTIFICATION TRAINING 
Patricia Gillette, Application Administrator, Human Subjects Office, University of Iowa  
10:30  BREAK 
10:45 E-TABLET TRAINING 
Brad McDowell, PhD, Director, Population Research Core at the University of Iowa Holden Comprehensive Cancer Center  
11:15  A RANDOMIZED CLINICAL TRIAL TO IMPROVE COLORECTAL CANCER SCREENING IN IOWA FAMILY PHYSICIAN PRACTICES 
Barcey Levy, PhD, MD, Professor, University of Iowa Department of Family Medicine  
11:45  LUNCH (Provided) & CONTINUED E-TABLET DISCUSSION 
12:15  USE OF THE FECAL IMMUNOHISTOCHEMICAL TEST 
Jeanette Daly, PhD, RN, Associate Research Scientist, University of Iowa Department of Family Medicine  
12:45  COLORECTAL CANCER SCREENING RESOURCES  
Sara Comstock, MSW, Executive Director, Iowa Cancer Consortium 
1:15 p.m. CLOSING & EVALUATIONS 
Barcey Levy, PhD, MD 
Nonprofit Org 
U.S. Postage 
PAID 
 
UNIVERSITY of IOWA 
1. Ely JW, Kaldjian LC, D’Alessandro DM. Diagnostic errors in primary care: lessons learned. Journal of the American Board  of   
Family Medicine, 2012;25(1):87-97. 
2. Daly JM, Levy BT, Xu Y. Quality of colonoscopy services for physicians in the Iowa Research Network. Family Medicine,  2012;44
(3):164-170. 
3. Levy BT, Daly JM, Xu Y, Ely J. Mailed fecal immunochemical tests plus educational materials to improve colon cancer screening 
rates in Iowa Research Network (IRENE) practices. Journal of the American Board of Family Medicine, 2012;25(1):73-82. 
4. Daly JM, Xu Y, Ely JW, Levy BT. A randomized colorectal cancer screening intervention trial in the Iowa Research Network:  
Study recruitment methods and baseline results. Journal of the American Board of Family Medicine, 2012;25(1):63-72. 
5. Daly JM, Xu Y, Levy BT, Bedell DA, Marquardt MD, Vonderhaar KM, James PA. Implementation of a diabetes management 
program for patients in a rural primary care office. Journal of Primary Care and Community Health, 2012;3(2):88-98.  
 
If you are interested in receiving a copy of any of the above publications, please email the request to IRENE@uiowa.edu. 
University of Iowa 
Carver College of Medicine 
Department of Family Medicine 
200 Hawkins Drive, 01105 PFP 
Iowa City, IA  52242-1097 
IOWA RESEARCH NETWORK 
We’re on the web!    
http://www.uihealthcare.com/depts/med/familymedicine/research/irene/index.html 
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2012 Iowa Cancer Summit:  
A Decade of Collaboration 
 
October 3-4, 2012 
 
West Des Moines Marriott 
 
To register or for more information: 
http://iowacancerconsortium.wildapricot.org/  
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Attendee Name: 
Role in Office: 
Contact Name: 
(if different than attendee) 
Phone: 
E-mail: 
Please check the session for which you are registering: 
□ Decorah, IA – 8/8/12 
 
Attendees will be trained in Human Subjects Protection ($200/person or up to $400 incentive for 
each office completing the training).  Please indicate to whom the check should be made payable: 
Name:   __________________________________________________________________ 
□ Same address as listed above 
□ Different mailing address 
Street address:     __________________________________________________________ 
City, State, Zip:   __________________________________________________________ 
  
Each IRENE clinic which sends a staff member to the training is eligible for a computer and print-
er or an e-tablet for clinic use.  Please check which option your clinic chooses: 
□ Desktop computer and printer 
□ E-tablet 
Travel:  Mileage, food and hotel (if requested) are provided to all attendees.  Indicate if you will 
be requesting travel reimbursement: 
□ Yes 
□ No 
Dietary restrictions or other needs: 
  
Iowa Primary Care Infrastructure Training (2012) 
Registration Form (complete one for each attendee) 
Please register by July 27th, 2012 
 
Fax Registrations to Kelly Rollins at 319-335-4072 (no cover sheet needed) 
 
Iowa Cancer Consortium, 100 MTP4, Room 162, Iowa City, IA  52242 
kelly-rollins@uiowa.edu  Phone:  319-384-1741 
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Meta-network Learning And Research Center (Meta-LARC) 
 
The Agency for Healthcare Research and Quality (AHRQ) released a funding 
announcement for Research Centers in Primary Care Practice Based Research and 
Learning. The Iowa Research Network (IRENE) worked with L.J. Fagnan, MD at the 
Oregon Rural Practice-based Research Network and submitted a proposal. This past 
month we learned it has been funded! 
 
The new Research Center in Practice-Based Research is a collaboration of six well-
established practice-based research networks (PBRNs) that joined together to create the 
Meta-network Learning and Research Center (Meta-LARC).  Meta-LARC’s mission is to 
sustain a consortium of PBRNs dedicated to increasing the quality, effectiveness 
and safety of primary care through accelerated research and collaborative learning.  
Meta-LARC members include the Oregon Rural Practice-based Research Network (ORPRN, Center home), the Iowa 
Research Network (IRENE), State Networks of Colorado Ambulatory Practices and Partners (SNOCAP), Oregon’s Safety Net 
West Practice-based Research Network (SNW), the Quebec Practice Based Research Network (QPBRN), and the Wisconsin 
Research and Education Network (WREN). These PBRNs are comprised of 533 primary care practices and over 6,000 
clinicians who provide care for an estimated three million patients in rural, urban, and underserved communities.  Combined, 
the networks have conducted over 200 studies and published nearly 200 scientific publications. 
 
The specific aims of Meta-LARC are described below: 
 
Aim 1: Foster the capabilities of six PBRNs and 533 primary care practices through a robust collaboration designed 
to conduct research to improve the quality, effectiveness and safety of primary care. 
We will build on the strengths of each network when responding to research opportunities and enlist the expertise of 
investigators, biostatisticians, bioinformaticists, and community practices from the collaborating institutions to form 
effective interdisciplinary teams. Studies will be appropriately powered and designed to take into account the variability 
across sites.  All six networks have identified practice redesign and transformation into Medical Homes and Neighbor-
hoods as a priority. 
 
Aim 2: Accelerate the conduct of PBRN research through a well designed, high functioning common infrastructure 
that enables the efficient conduct of research. 
The Administrative Core and Research Core will be housed within ORPRN at Oregon Health and Science University 
(OHSU), but will draw from best practices and methods of the collaborating PBRNs and the PBRN literature. Each of the 
cores’ structures and operating procedures are designed to be nimble in responding to research opportunities, effective in 
implementing research protocols across a variety of clinic models, and positioned to advance PBRN study methodology 
through best practices frameworks and inter-PBRN synergy. Meta-LARC will develop opportunities and a structure for 
senior investigators to partner with junior researchers and research fellows to understand and become familiar with PBRN 
research methods. 
 
Aim 3: Promote continuous learning and sharing across Meta-LARC networks and practices to accelerate 
the dissemination of knowledge and bi-directional communication. 
Through a structured learning collaborative and the use of the online Clinical and Translational Science Award (CTSA)-
developed ShareCenter tool, networks and their member clinicians will be exposed to research findings more quickly, be 
empowered to communicate with colleagues, and be encouraged to participate more fully in PBRN research. Meta-LARC 
will emphasize knowledge translation research and uptake into primary care practices, using the methods and 
approaches developed by the QPBRN and their Canadian collaborators. 
FUNDING ANNOUNCEMENTS 
Network & Headquarters Location Institutional Affiliations Principal Investigator 
ORPRN—Portland, OR Oregon Health & Science University Lyle Fagnan, MD (Consortium PI) 
IRENE—Iowa City, IA University of Iowa College of Medicine Barcey Levy, PhD, MD 
QPBRN—Quebec City, Quebec, Canada University of Laval Medical School France Légaré, MD, PhD 
SNW—Portland, OR OCHIN, Kaiser NW, OHSU Jennifer DeVoe, MD 
SNOCAP  (Consortium of 3 Networks)—Denver, CO University of Colorado School of Medicine Donald Nease, MD 
WREN—Madison, WI University of Wisconsin School of Medicine Paul Smith, MD 
